The Power of a Laboratory in the Palm of Your Hand
BurstDX exists to empower users with simple, accurate, quantitative testing — delivered when and where it matters most.
CaDI is the platform at the core of BurstDX. It was built around a simple belief: highly sensitive, quantitative results should not be limited to complex laboratory settings.
By rethinking how precision testing is delivered, CaDI preserves lab-level sensitivity while simplifying how and where testing can be deployed — from the point of need to at-home use.
The result is a rapid, cost-effective system that revolutionizes what immunoassays can achieve.
Rapid. Accurate. Quantitative. Cost-Effective.
Meet CaDI
A Platform for Quantitative Insights
We believe that better decisions begin with better measurement. That’s where CaDI comes in.
From empowering individuals with at-home hormone insights to enabling partners with custom assays across industries, CaDI supports high-sensitivity performance wherever reliable measurement is needed. Experience the power of 10-minute, cost-effective, quantitative testing all in one compact cartridge.
-
![]()
“Working with Burst really helped our team accelerate progress towards our first working product. We really appreciated their quick turnarounds and speed of execution. They bring a wealth of knowledge in microfluidics and by the end of the project it felt like they had become an extension of our own team.”
CEO/Founder | Anonymous Custom Assay Development Partner
-
![Portrait of a man with gray hair, wearing a blue shirt and a dark jacket, smiling slightly.]()
"The ultra-sensitive, quantitative platform Burst is developing has the potential to transform multiple industries — from wellness monitoring to next-generation food safety testing. This is an exciting time for rapid testing.”
Dr Larry Jia | CEO, Zymo Research
Partner, Early Investor -
![]()
“BurstDX’s ability to adapt to new assay chemistries is matched only by their commitment to timely delivery. Whether responding to emerging scientific demands or evolving needs, BurstDX has consistently pivoted with precision and without missing a beat.”
CEO/Founder | Anonymous Custom Assay Development Partner
-
![A smiling man in a blue button-up shirt stands against a grey background.]()
“Burst Diagnostics is building a test that will revolutionize the POC market by introducing a solution that yields laboratory-quality results in near real-time.”
Tim Jones | COO, Innosphere Ventures
Fund Principal, Early Investor -
![A man in a dark suit with a light dress shirt smiling in front of a green background.]()
"We’re excited to support Burst Diagnostics as they develop simple, convenient, and affordable antigen tests that can provide lab-quality results; they’re disrupting point-of-care diagnostics before our eyes."
Mike Freeman | CEO, Innosphere Ventures
General Partner, Early Investor
